Correlation Between Intra Cellular and Evolus

Can any of the company-specific risk be diversified away by investing in both Intra Cellular and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intra Cellular and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Intra Cellular Therapies and Evolus Inc, you can compare the effects of market volatilities on Intra Cellular and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intra Cellular with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intra Cellular and Evolus.

Diversification Opportunities for Intra Cellular and Evolus

0.0

Correlation Coefficient

Intra Cellular  Evolus

Pay attention - limited upside

The 3 months correlation between Intra and Evolus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Intra Cellular Therapies and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Intra Cellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intra Cellular Therapies are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Intra Cellular i.e., Intra Cellular and Evolus go up and down completely randomly.

Pair Corralation between Intra Cellular and Evolus

If you would invest (100.00) in Intra Cellular Therapies on May 17, 2025 and sell it today you would earn a total of  100.00  from holding Intra Cellular Therapies or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Intra Cellular Therapies  vs.  Evolus Inc

Intra Cellular Therapies

Risk-Adjusted Performance

Weakest

Over the last 90 days Intra Cellular Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Intra Cellular is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.

Evolus Inc

Risk-Adjusted Performance

Weakest

Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Intra Cellular and Evolus

The main advantage of trading using opposite Intra Cellular and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intra Cellular position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.

The idea behind Intra Cellular Therapies and Evolus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.